什么时候安慰剂效应会对网络元分析结果产生影响?
Adriani Nikolakopoulou1, Anna Chaimani2, Toshi A Furukawa3
1Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany adriani.nikolakopoulou@uniklinik-freiburg.de.
BMJ evidence-based medicine
|June 29, 2023
概括
由患者的信念驱动的安慰剂效应可能会导致随机对照试验结果偏差. 这项研究在元分析中确定了安慰剂偏差的红旗,使用组件网络元分析来估计安慰剂效应.
科学领域:
- 临床试验方法论 临床试验方法论
- 证据综合 证据综合
- 心理治疗研究 心理治疗研究
背景情况:
- 由模拟治疗预期产生的安慰剂效应,在临床试验中显著影响主观症状评估.
- 诸如失明质量和研究设计等因素可以影响安慰剂反应,并引入随机对照试验 (RCT) 的偏见.
- 这种偏见可以传播到系统性审查中,影响对对和网络元分析.
研究的目的:
- 在对对和网络元分析中识别潜在安慰剂效应偏差的指标 ("红旗").
- 探索使用组件网络元分析对安慰剂效应的估计.
- 将这些方法应用于真实世界的数据集,检查抑郁症心理治疗.
主要方法:
- 利用组件网络元分析来量化安慰剂效应.
- 分析了关于抑郁症治疗的发布网络元分析,包括123项研究.
- 检查了研究特征对安慰剂反应和潜在偏差的影响.
主要成果:
- 证明了组件网络元分析用于估计安慰剂效应的应用.
- 提供了一个框架,用于识别因安慰剂反应而导致的元分析中的潜在偏差.
- 分析的重点是心理治疗与抑郁症对照治疗的相对有效性.
结论:
- 安慰剂效应可以显著偏差元分析结果,需要在证据合成中仔细考虑.
- 组件网络元分析为估计和理解安慰剂效应提供了有价值的工具.
- 识别和解决安慰剂偏差对于在系统性审查中准确解释治疗有效性至关重要.
相关概念视频
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:52Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
01:29Bias in Epidemiological Studies
369
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
369